Brief: Ryvu Therapeutics Q1 Net Loss Widens To 26.5 Mln Zlotys
18/05/2022 16:28
May 18 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q1 NET LOSS OF 26.5 MILLION ZLOTYS VERSUS LOSS OF 13.6
MILLION
ZLOTYS YEAR AGO
* Q1 REVENUE FROM SALES 0.2 MILLION ZLOTYS VERSUS 0.4
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING LOSS OF 26.8 MILLION ZLOTYS VERSUS LOSS OF
15.7
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM6lcfhXa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project